Presbyopia is a common age-related vision problem that usually first manifests in the 40s or 50s. The capacity of the eye to focus on close things, like text on a page or product labels, gradually disappears as a result of it. Presbyopia is the most common cause of visual impairment, affecting almost 1.8 billion people worldwide, according to a Community Eye Health Journal analysis. Presbyopia, which causes trouble seeing up close, is a normal aspect of aging, according to the Mayo Clinic. It is caused by the eye’s lens becoming less flexible. People who live into their 50s and beyond almost always have this ailment, and it affects both those who wear contacts or glasses and those who don’t.
Mumbai-based Entod Pharmaceuticals has unveiled a novel treatment to counteract the problems associated with presbyopia. PresVu Eye Drops, which the business created, are being hailed as a possible game-changer for those with presbyopia. The eye drops are deemed credible and safe because the Drug Controller General of India (DCGI) has approved them and the Central Drugs Standard Control Organization (CDSCO) has recommended them.
The CEO of Entod Pharmaceuticals, Nikkhil K. Masurkar, stressed the importance of this approval, saying that it represents a significant turning point for the business. He was optimistic that PresVu Eye Drops would change the way eye care is provided in India and enhance millions of people’s lives by maybe lowering the need for reading glasses. The goal of the eye drops is to give people who suffer from presbyopia an alternate option while also enhancing their visual independence and comfort.
One significant development in the field of eye care is the creation of PresVu Eye Drops. If effective, this device might drastically change how presbyopia is managed by providing a non-surgical means of assisting individuals in regaining clarity in their near vision. Entod Pharmaceuticals’ discovery offers a hopeful step forward in enhancing the quality of life for people with presbyopia by addressing a common problem that affects a significant number of the aging population.
SOURCE :
HINDUSTAN TIMES
